Astronics Corp. 10-Q Summary: Q2 2024
Business Context and Reporting Period
Astronics Corporation (ATRO) is a provider of advanced technologies to the global aerospace, defense, and electronics industries. This report covers the quarterly period ended June 29, 2024. The company operates through two primary segments: Aerospace (commercial transport, military, general aviation) and Test Systems (government/defense and mass transit).
Key Financial Metrics
| Metric | Q2 2024 (3 Months) | Q2 2023 (3 Months) | YTD 2024 (6 Months) | YTD 2023 (6 Months) |
|---|---|---|---|---|
| Sales | $198.1 million | $174.5 million | $383.2 million | $331.0 million |
| Gross Profit | $41.4 million | $32.7 million | $75.5 million | $60.2 million |
| Gross Margin | 20.9% | 18.7% | 19.7% | 18.2% |
| Operating Income | $7.6 million | $2.4 million | $9.2 million | $0.03 million |
| Net Income (Loss) | $1.5 million | ($12.0 million) | ($1.6 million) | ($16.4 million) |
| Diluted EPS | $0.04 | ($0.37) | ($0.05) | ($0.50) |
| Cash & Restricted Cash | $4.4 million (as of June 29, 2024) | |||
| Long-Term Debt | $172.6 million (as of June 29, 2024) | |||
| Backlog | $633.4 million (as of June 29, 2024) |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated sales increased 13.6% in Q2 and 15.8% YTD compared to the prior year. Aerospace sales drove the majority of this growth, particularly in Commercial Transport (+14.6% Q2) and Military Aircraft (+82.4% Q2).
- Profitability Improvement: The company returned to profitability in Q2 2024 ($1.5M net income) compared to a significant loss in Q2 2023. Operating margins expanded to 10.9% in the Aerospace segment (up 220 bps) due to volume leverage and efficiency.
- Test Systems Performance: While Test Systems sales increased, the segment reported an operating loss of $5.3M in Q2. This was impacted by a $3.5M revenue reduction due to revised cost estimates on mass transit contracts, partially offset by new U.S. Army radio test sales.
- Expense Increases: SG&A and Cost of Products Sold increased due to the resumption of incentive bonus programs ($2.0M in Q2) and higher litigation-related legal expenses ($3.0M in Q2).
- Cash Flow: Operating cash flow usage improved significantly to $4.2M YTD 2024 from $21.2M usage in YTD 2023, driven by better financial results and improved working capital management.
Guidance, Outlook, and Risks
- Debt Restructuring (Subsequent Event): On July 11, 2024, the company amended its credit facilities. The ABL Revolving Credit Facility was increased to $200 million (from $115M) and extended to 2027. A new $55 million Term Loan was established. The company expects to record a $7.0 million loss on debt extinguishment in Q3 2024.
- Liquidity: The company maintains compliance with debt covenants but notes that liquidity is highly dependent on achieving expected operating results. Net debt was $174.0 million as of June 29, 2024.
- Legal Contingencies: Significant litigation with Lufthansa Technik AG regarding patent infringement continues. Reserves of approximately $17.3 million (Germany) and $7.3 million (UK) are recorded. A damages trial in the UK is scheduled for October 2024.
- Restructuring: The Test Systems segment implemented restructuring in April 2024, closing a Texas operation, with expected annual savings of $4 million starting in Q3.
- Risks: Key risks include supply chain pressures, labor availability, customer concentration (Boeing represents ~11% of sales), and the potential for covenant violations if operating results decline unexpectedly.
Investor Verification Checklist
- Debt Extinguishment Impact: Verify the timing and magnitude of the expected $7.0 million loss on debt extinguishment in Q3 2024 and its effect on full-year earnings.
- Litigation Exposure: Monitor the outcome of the UK damages trial (Oct 2024) and the French Supreme Court appeal regarding Lufthansa patent disputes.
- Test Systems Turnaround: Assess whether the new U.S. Army contract and restructuring savings are sufficient to offset the segment's structural operating losses and low volume.
- Covenant Compliance: Review the company's ability to maintain the minimum fixed charge coverage ratio (1.10:1) and minimum excess availability ($15M) under the new credit terms.
- Working Capital Trends: Confirm if the improvement in accounts receivable and inventory cash usage is sustainable or a one-time benefit from supply chain normalization.